Lifshitz Law Firm, P.C. Announces Investigation of Cellular Biomedicine Group, Inc., GCI Liberty, Inc., Jernigan Capital, Inc., and NTN Buzztime, Inc.
NEW YORK, Sept. 01, 2020 (GLOBE NEWSWIRE) --
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CBMG to members of CBMG management.
If you are a CBMG investor, and would like additional information about our investigation, please complete the Information Request Form.
GCI Liberty, Inc. (NASDAQ: GLIBA) - Liberty Broadband Corporation (NASDAQ GS: LBRDK)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of GLIBA to LBRDK.
If you are a GLIBA or LBRDK investor, and would like additional information about our investigation, please complete the Information Request Form.
Jernigan Capital, Inc. (NYSE: JCAP)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of JCAP to an affiliate of NexPoint Advisors, L.P.
If you are a JCAP investor, and would like additional information about our investigation, please complete the Information Request Form.
NTN Buzztime, Inc. (NYSE: NTN)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of NTN with Brooklyn ImmunoTherapeutics LLC.
If you are a NTN investor, and would like additional information about our investigation, please complete the Information Request Form.
ATTORNEY ADVERTISING.© 2020 Lifshitz Law Firm, P.C. The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law Firm, P.C.
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
